Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
Scopus BioPharma (NASDAQ:SCPS) Shares Down 8.3%
Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Significant Increase in Short Interest
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Stocks That Hit 52-Week Lows On Monday
12 Health Care Stocks Moving In Monday's Intraday Session
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Short Interest in Scopus BioPharma Inc. (NASDAQ:SCPS) Decreases By 38.0%
12 Health Care Stocks Moving In Thursday's After-Market Session
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Federal Reserve's Still-Hawkish Stance Appears to Disappoint Investors; US Futures Move Lower
Top Premarket Gainers
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
No Data
No Data